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Little is known of molecular requirements for speciﬁcation of human germ cells. However, it is likely that they
are speciﬁed through the action of sequentially expressed genes just as in model organisms. We sought to
determine whether human embryonic stem (ES) cell lines, like those of mice, might be capable of forming
germ cells in vitro. We compared transcriptional proﬁles of three pluripotent human ES cells to those of
isolated inner cell mass (ICM) cells. We found that ICM cells expressed NANOS1, STELLAR and OCT4,
whereas undifferentiated human ES cells expressed these genes along with the germ cell-speciﬁc gene,
DAZL. Upon ES cell differentiation into embryoid bodies (EBs), we observed a shift in expression from RNA
and protein markers of immature germ cells to those indicative of mature germ cells, including expression of
VASA, BOL, SCP1, SCP3, GDF9 and TEKT1. Although ability to test the function of these putative VASA
positive germ cells is limited, these results demonstrate that differentiation of human ES cells into EBs
in vitro results in formation of cells that express markers speciﬁc to gonocytes.
INTRODUCTION
Two divergent developmental programs are associated with
speciﬁcation of the germ cell lineage in model organisms. In
non-mammalian species of fruitﬂies, nematodes and frogs,
germ cells of both males and females are speciﬁed via the
inheritance of germ plasm, microscopically distinct oocyte
cytoplasm that is particularly rich in RNAs and RNA-binding
proteins and segregates with cells destined to be germ cells
(1,2). Some of the RNAs and RNA-binding proteins such as
Pumilio, Nanos and Dazl are highly conserved between
organisms that specify germ cells via germ plasm inheritance,
and those that form germ cells independently of germ plasm,
such as mammals (2–5).
Fate mapping studies have been used to examine germ cell
speciﬁcation in mammals and have revealed that germ cells
are speciﬁed in the proximal epiblast in mice (6), in response to
signals from the neighboring extraembryonic ectoderm, in
particular Bmp4 signaling (7). However, it is notable that the
proximal epiblast is not predestined to a germ cell fate since
transplantation of the distal epiblast to contact the extra-
embryonic ectoderm also results in germ cell formation (6).
Furthermore, the fate of proximal epiblast cells is ultimately to
form both germ cells and extraembryonic mesoderm. Thus, it is
likely that the extraembryonic ectoderm provides one of the
ﬁrst signals for germ cell speciﬁcation in the epiblast, and then,
a second as yet uncharacterized signal is required to distinguish
extraembryonic mesoderm from germ cells. Germ cells are ﬁrst
recognized following gastrulation, at 7.2 days post coitum
(dpc), as an extraembryonic cluster of cells at the base of the
allantois that express tissue non-speciﬁc alkaline phosphatase
(TNAP), Oct4 and stella (8–11). Although epiblast cells
migrate through the primitive streak during gastrulation, the
physical act of migration does not appear to be necessary for
deﬁning germ cell versus somatic cell fates (12–14).
The embryological period equivalent to mouse E5.5–E7.2 in
human embryo development occurs shortly after implantation.
Thus, the analysis of human germ cell speciﬁcation in vivo is
impracticable due to ethical considerations regarding research
during this period. However, recent studies in mice have shown
that embryonic stem (ES) cells (derived from the inner cell
mass of the blastocyst prior to epiblast formation) are capable
of differentiating into female and male germ cells in vitro
(15,16). Oocyte differentiation from mouse ES cells was
obtained via spontaneous differentiation of adherent cultures,
as indicated by analysis of germ cell-speciﬁc markers such as
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morphology and follicular steroidogenic enzyme production
(15). Male germ cell differentiation was also demonstrated via
differentiation of mouse ES cells into embryoid bodies (EBs)
and analysis of germ cell-speciﬁc markers (16). Putative PGCs
(primordial germ cells) derived from the ES cells were then
transplanted into adult testis where they formed cells with
morphological characteristics of sperm (16). In addition, while
this manuscript was under review, it was further demonstrated
that the imprinting status of genes such as Igfr2 was
appropriate for putative PGCs and that haploid male gametes
derived from ES cells were subsequently capable of fertilizing
oocytes in vitro and subsequent development to blastocyst stage
(17). Taken together, these studies indicated that mouse ES
cells are capable of spontaneously forming germ cells in vitro.
In contrast, it is not known whether human ES cell lines
possess the ability to contribute to the germ cell lineage.
Indeed, one might wonder if this ability might be limited given
that all human ES cell lines have been derived from embryos
donated by infertile couples. Thus, we sought evidence that
human ES cells could contribute to germ cell formation in vitro
by differentiating three human ES cell lines to EBs and
assessing expression of RNA and protein markers diagnostic of
germ cell development. Markers examined in studies of mouse
ES cell differentiation to the germ cell lineage were included in
all experiments (15–17).
RESULTS
Many studies in both mice and humans have shown that ES
cells have the capacity to proliferate and to differentiate to
numerous cell lineages. Using in vitro studies, mouse ES cells
have been shown to differentiate into lineages that include
hematopoietic, vascular, pancreatic, neural, muscular and germ
cells (15–26). Likewise, human ES cells have also been shown
to differentiate to several lineages in vitro, including neural,
pancreatic, muscular, endothelial, trophoblast and hematopoie-
tic cells (27–36). In all of these studies, a combination of
approaches, including analysis of molecular markers speciﬁ-
cally expressed in relevant cell types and morphological and/or
histochemical approaches, was used to deﬁne differentiated cell
types. Therefore, in order to identify germ cells in different
stages of formation and differentiation during human EB differen-
tiation, we compiled a list of markers that are germ cell-speciﬁc
(not expressed in somatic lineages), and germ cell-enriched
(highly expressed in germ cells with limited expression in
somatic cells). From this list, we generated a proﬁle of the
expected sequential expression of markers that would deﬁne
development of the germ cell lineage during ES cell differen-
tiation in vitro (Fig. 1).
Pre-meiotic germ cell markers are expressed in
human ES cells
We began our studies by examining gene expression in three
lines of undifferentiated ES cells that were either cytogenetically
46;XX (HSF-6 and H9) or 46;XY (HSF-1). As expected from
previous reports (37,38), we observed consistently high expres-
sion of the human OCT4 gene in all three human ES cell lines
(Fig. 1; Table 1). This assured us that our starting population of
cells contained pluripotent cells since OCT4 expression is
restricted to pluripotent ES cells and germ cells (10,39). Then,
we examined expression of additional embryonic stem cell and/
or germ cell-speciﬁc and germ cell-enriched genes in order to
establish baseline proﬁles of expression of genes reportedly
expressed in human ES cells and/or human germ cells. These
genes included the GDF3 (growth and differentiation factor 3),
STELLAR (STELLA-related), NANOG (the human homolog of
mouse nanog), NANOS1, DAZL (deleted in azoospermia-like),
VASA, cKIT, PUM1 (PUMILIO 1), PUM2 (PUMILIO 2), SCP1
(synatonemal complex protein 1), GDF9 (growth and differ-
entiation factor 9), and TEKT1 (TEKTIN 1)g e n e s .O ft h e s e
genes, we found that the GDF3, NANOG and STELLAR genes
were expressed in undifferentiated ES cells, as previously
reported (38). In addition, we also observed expression of the
germ cell-speciﬁc gene DAZL in all three lines of undiffer-
entiated human ES cells, as well as the germ cell-enriched genes
cKIT (a marker of pre-meiotic migrating germ cells), NANOS1,
PUM1 and PUM2 (markers of pre-meiotic germ cells of the fetal
gonads; Fig. 2A, Table 1). In contrast to these genes, whose
expression is diagnostic of pre-meiotic germ cells, we did not
observe expression of genes that are known to be restricted in
expression to later stages of germ cell differentiation. Thus, we
Figure 1. Diagrammatic representation of the different stages of germ cell dif-
ferentiation in fetal and adult development. Expected expression patterns of
genes used to predict each stage of germ cell development are shown by
the name of the gene together with the black bars extending to the right of
each gene name. All genes shown are enriched in germ cells relative to
somatic cells; those that are only expressed in germ cells following gastrula-
tion in vivo are indicated by an asterisk. Thus, genes known to be expressed in
undifferentiated human ES cells include: OCT4 (73,74); GDF3, Growth and
Differentiation Factor 3; NANOG; STELLAR (38); PUM1, PUMILIO 1;
PUM2, PUMILIO 2 (3) and NANOS 1 (4). Genes known to be expressed in
PGC development through to later stages of germ cell differentiation include
DAZL, Deleted in AZoospermia-Like (44); c-kit (mouse) (75,76); stella
(mouse) (9) and Nanos (mouse and ﬁsh) (5,77). Genes known to be expressed
from gonocyte formation includes VASA (40). Genes expressed during meiosis
include: SCP1, Syntaptonemal Complex Protein 1 and 3 (41); MLH1, Mut-L
Homolog 1 (78) and BOULE (45). Adult oocyte-speciﬁc marker: Gdf9,
Growth and Differentiation Factor 9 (mouse) (42). Adult spermatid speciﬁc
marker: TEKT1, Tektin1 (43).
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and TEKT1 (Fig. 2A) or BOULE and SCP3 (data not shown),
which are speciﬁc markers of germ cells during their later stages
of migration as they enter the gonads and progress through
meiosis and gamete morphogenesis (Fig. 2A; Table 1) (40–43)
Since undifferentiated human ES cells expressed a number of
markers indicative of putative premeiotic germ cells, we tested
whether germ cell speciﬁc proteins were also expressed in
undifferentiated human ES cells (Fig. 2B). Western blot analysis
ofhumanfetalandadulttestistissuewasusedasapositivecontrol
since the transcriptional and translational proﬁles of these tissues
have been well documented (3,4,40,44,45). As expected, the fetal
testis expressed PUM2, OCT4, NANOS1, DAZL and VASA
proteins, whereas the meiotic proteins, BOULE and SCP3, were
conﬁnedtoadulttestis(Fig.2B).Bycomparison,undifferentiated
human ES cells expressed PUM2, OCT4, NANOS1 and DAZL
proteins, but not markers of later germ cell development such as
VASA, BOULE or SCP3 (Fig. 2B). These results, along with the
transcriptional proﬁles, indicated that undifferentiated human ES
cells expressearly markers of germ celldevelopmentbut not later
markers of germ cell development such as VASA, at both the
mRNA and protein levels.
Although western blot analysis provided a general proﬁle of
protein expression, it did not reveal expression of proteins in
undifferentiated ES cells at the single cell level. Therefore, we
used immunohistochemical methods to examine expression of
proteins in undifferentiated ES cells (Fig. 3). We began by
conﬁrming that colonies of ES cells stained positively for the
cell surface markers SSEA-3 and TRA-1-81, which are known
to be expressed only in undifferentiated ES cells (Fig. 3A). We
then examined expression of the markers STELLAR, DAZL,
VASA, KDR, AFP and NCAM1. We observed that STELLAR
protein was localized to the majority of ES cells in most
colonies where it was present in both the cytoplasm and
nucleus (Fig. 3B and C). Analysis of DAZL protein distribution
indicated a distribution similar to that of STELLAR; it was
detected in the majority of cells in a given ES cell colony
(Fig. 3D and E). In contrast to the expression of the STELLAR
and DAZL proteins in the majority of cells in most ES cell
colonies, expression of VASA was not detected in any
undifferentiated human ES cell colonies (data not shown).
Also, in contrast to the expression of STELLAR and DAZL,
protein expression of the somatic markers KDR and AFP was
only rarely seen and then it was conﬁned to cells at the edges of
ES cell colonies (Fig. 3F and G). Notably, we could not detect
NCAM1 protein in undifferentiated ES cells (Fig. 3H); this was
in spite of the fact that the RNA was clearly detected, as
indicated above (Fig. 2). Only with differentiation of ES cells to
form EBs, followed by adherent culture for 5 days, was the
expression of NCAM1 in the cell cytoplasm of differentiated
ES cells observed (Fig. 3I). We conﬁrmed and extended these
immunoﬂuorescence results with more sensitive immunohis-
tochemistry. We noted that DAZL and STELLAR were present
in the majority of undifferentiated ES cells (Fig. 3J and K), but
were certainly not expressed in every cell (see insets of Fig. 3J
and K). As noted above with immunoﬂuorescence, VASA
expression was also undetectable in undifferentiated human ES
cells by immunohistochemistry (Fig. 3L).
Expression of germ cell markers in the
human inner cell mass
Expression of STELLAR and DAZL mRNA and protein in the
majority of human ES cells in undifferentiated colonies was
unexpected. In particular, in diverse model organisms that
include species of ﬂies, worms, frogs, ﬁsh, salamanders, mice
and non-human primates, as well as in humans, the expression
of DAZ gene family homologs has been shown to be restricted
entirely to the germ cell lineage (44,46–63). Thus, the observa-
tion that premeiotic germ cell genes, including DAZL, were
expressed in undifferentiated human ES cells raised several
possibilities: First, the expression of these genes may simply
reﬂect random, unregulated gene expression. However, if that
were the case, we might have also expected random expression
of later germ cell markers such as VASA, SCP1, SCP3, BOULE,
GDF9 and TEKT1. Yet, this was not the case. We observed the
Table 1. Real-time PCR in undifferentiated human ES cells
Gene name HSF-1 (10
3)H 9 ( 10
3) HSF-6 (10
3) P-value
(significance<0.01)
NCAM1 7.928.8 2.211.6 1.861.1 0.34
KDR 1.801.3 6.484.7 4.884.2 0.36
AFP 0.4375.3 1.843.1 3.950.2 0.39
OCT4 67.220 293119 304491 0.56
GDF3 1.060.1 5.551.9
a 0.2880.4
b 0.005*
STELLAR 4.035.0 1.261.9 0.1260.1 0.355
NANOG 11.12.4 35.521 2.762.3 0.041
NANOS 1.501.6 0.6630.6 0.6810.4 0.54
VASA 00 0 N D
DAZL 0.0831.4 0.4550.7 0.3980.2 0.83
KIT 1.530.1 4.717.6 1.080.2 0.58
PUM1 11.05.0
b 35.76.9
a 4.824.2
c 0.001*
PUM2 10.17.8 67.383.7 25.528.0 0.42
SYCP1 00 0 N D
GDF9 00 0 N D
TEKTIN1 0 0 0.00006730.000011 0.24
Mean normalized expression of genes in HSF-1, H9 and HSF-6 calculated by REST (72). Signiﬁcance was calculated by ANOVA for each gene followed by two
tailed t-test. Signiﬁcance (P 0.01) between a–b and a–c. ND, ‘not done’.
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assayed but none of the meiotic and postmeiotic germ cell
markers at both the mRNA and protein levels. Second, it is
possible that human ES cells and germ cells share aspects of a
common molecular program and therefore express similar
genes. We could not discount this possibility based on our data.
In fact, expression analysis of genes such as OCT4, NANOG,
STELLAR and GDF3 lends further credence to this possibility
(38,39). Third, expression of genes such as DAZL may indicate
spontaneous differentiation of a subpopulation of ES cells into
germ cells. Supporting this possibility was the observation that
undifferentiated human ES cells also expressed detectable levels
of mRNA markers of the differentiated ectoderm, mesoderm
andendodermsomaticlineages[neuralcelladhesionmolecule1
(NCAM1), alphafetoprotein (AFP) and tyrosine kinase receptor
(KDR), respectively; Fig. 2A; Table 1]. In order to address
which of these possibilities was most likely, we compared the
expression of several genes in the ICM to that of the undifferen-
tiated human ES cell lines (Fig. 4, A–C). Notably, we found that
human ICM cells expressed the gene STELLAR at consistently
higher levels than OCT4 (Fig. 4A; Table 2). Furthermore, we
also found that ICM cells expressed NANOS1 but not the
somatic marker NCAM1, the premeiotic germ cell markers
DAZL and later germ cell markers such as VASA or SCP1
(Fig. 4A). Owing to limited availability of human ICMs for
analysis, additional markers could not be assayed. Nevertheless,
these results illustrated that undifferentiated human ES cells
differ in regard to DAZL and NCAM1 transcription compared
to their in vivo counterpart ICM cells (Fig. 4A and B). These
results also suggest that removal of the ICM from the blastocyst
and subsequent culturing on mouse embryonic feeder cells
(MEFs) resulted in transcription of DAZL and NCAM1 in
ES cells, markers which are normally not expressed in the ICM
of blastocysts. Therefore, if we focus on differentiation towards
a germ cell-speciﬁc pathway, removal of the ICM from
blastocysts may result in spontaneous differentiation of
cells towards the germ cell lineage based on the expression
of the germ cell-speciﬁc gene DAZL. However, the next
in vivo temporal marker of germ cell differentiation, VASA, is
not expressed.
Meiotic and post-meiotic germ cell differentiation of
human ES cells in vitro
We noted above that undifferentiated ES cells express
STELLAR and DAZL in the majority of cells in a given colony.
Given that, in vivo, DAZL has only been shown to function in
germ cell formation and/or maintenance, we sought to determine
whether germ cell differentiation could be achieved with
embryoid body (EB) formation in vitro. Under differentiation
conditions, genes expressed exclusively or predominantly in
pluripotent cell types are expected to decrease whereas markers
of the somatic lineages are expected to increase as cells of the
somatic lineages differentiate. Indeed, that was the case; the
markers, OCT4, STELLAR, NANOG and GDF3 decreased with
differentiation, whereas NCAM1, AFP and KDR increased
(Fig. 5). Unexpectedly, however, by day 14 of differentiation,
expression of both the NANOS1 and DAZL genes decreased
dramatically as well. Conversely, there was a sharp increase in
expression of the later germ cell lineage markers including the
gonocyte marker VASA, the meiotic marker, SCP1,a n d
postmeiotic markers, GDF9 and TEKT1 as EB differentiation
progressed (Fig. 5). These results largely parallel those of mice
(15–17). However, in contrast to studies in mice, we observed
Figure 2. Analysis of expression of RNA and protein markers of the somatic
and germ cell lineages in undifferentiated human ES cells. Shown are PCR pro-
ducts separated by gel electrophoresis (A). PCR products were generated by
quantitative PCR using SYBR green for three different lines of undifferentiated
human ES cells, HSF-1, H9 and HSF-6. PCR reactions were performed in
duplicate on three different samples from each cell line. Four groups of markers
were assayed: (1) somatic lineage markers; (2) ES cell and germ cell speciﬁc
markers; (3) germ cell enriched markers that have expression in additional
somatic cell types; (4) meiotic and post-meiotic germ cell speciﬁc expression.
Relative expression values were also determined by referencing the CT value of
each test gene to GAPDH (Table 1). Shown is western blot analysis of fetal and
adult testis and undifferentiated human ES cells (B). Note that the fetal testis
contains premeiotic diploid germ cells only; meiosis is not initiated until pub-
erty. As expected, the fetal testis expressed PUM2, OCT4, NANOS1, DAZL
and VASA proteins and adult testis also expressed BOULE and SCP3 proteins.
Undifferentiated human ES cells have a similar expression proﬁle to fetal testis
in that the ES cells expressed the PUM2, OCT4, NANOS1 and DAZL proteins;
VASA, BOULE, SCP3 and GDF9 proteins were not detected. Note that,
although present, OCT4 expression in the fetal testis is very low, as previously
reported (39). The asterisk indicates the non-speciﬁc band identiﬁed in BOULE
pre-immune and immune sera as previously published (45).
730 Human Molecular Genetics, 2004, Vol. 13, No. 7that human germ cells differentiated in vitro expressed both the
male and female genetic programs regardless of whether they
were karyotypically XX or XY (Fig. 5). Expression of both
GDF9(anoocyte speciﬁc gene) andTEKT1(aspermatidspeciﬁc
gene) was noted with differentiation of all human ES lines.
Since transcriptional proﬁles indicated that VASA-positive
putative germ cells formed with ES cell differentiation, we
sought evidence that proteins diagnostic of germ cells might
also be expressed in EBs. At days 14 and 21 of culture, EBs
were sectioned and stained for the VASA, STELLAR and
DAZL proteins via immunohistochemistry. We observed that
VASA positive cells were most frequently observed in clusters,
at the edges of EBs and throughout small sections of EBs
(Fig. 6A and B). We noted that not all cells in a given EB were
positive for VASA, a ﬁnding consistent with our expectation
that somatic cell differentiation was occurring in parallel. We
observed that STELLAR-positive cells were more frequent
than VASA-positive cells, and were located throughout the EBs,
in clusters within EBs, and especially in cells lining the edges
of EBs (Fig. 6E–G). As was noted for VASA-positive cells, not
Figure 3. Analysis of cellular and subcellular protein expression in undifferentiated ES cells. Expression was analyzed via immunoﬂuorescence (A–I) and immu-
nohistochemistry (J–M). (A) The markers of undifferentiated ES cells, SSEA3 (green) and TRA-1-81 (red), were used to assess status of colony differentiation
(orange represents co-localization of SSEA3 and TRA-1-81. Also shown are: STELLAR immunoﬂuorescence (B) and DAPI (C); DAZL immunoﬂuorescence (D)
and DAPI (E); merged images of immunoﬂuorescence and DAPI for KDR (F) white arrow shows positive cell), AFP (G; white arrow indicates positive cells), and
NCAM1 (H). Note that NCAM1 protein is only detected in differentiating ES cells cultured on gelatin (I; white arrow indicates positive cytoplasmic expression).
Immunohistochemistry of STELLAR (J), DAZL (K) and VASA (L) is also shown. Insets show cells positive for STELLAR (J; black arrowhead) and DAZL (K;
black arrowhead); negative for STELLAR (J; white arrowhead) and DAZL (K; white arrowhead). Negative controls included both pre-immune sera (M), and pro-
cessing without the primary antibody (data not shown). Scale bars¼50mm.
Human Molecular Genetics, 2004, Vol. 13, No. 7 731every EB section contained STELLAR-positive cells. Finally,
examination of the localization of DAZL protein in EBs
revealed that DAZL-positive cells were found in more EBs
than either STELLAR- or VASA-positive cells (Fig. 6H–J).
However, when adjacent sections were stained for STELLAR
and DAZL, most often cells within the same region of the EB
stained for both proteins (for example, compare Fig. 6F and I).
Furthermore like STELLAR, DAZL-positive cells were more
likely to be found evenly dispersed throughout EBs composed
of loosely packed cells (Fig. 6I and J). Cell numbers positive
for DAZL, STELLAR and VASA were tallied for adjacent
sections of the same EB and conﬁrmed visual impressions of
immunohistochemistry (Fig. 7). Given these tallies, clearly the
fate of all cells that are positive for DAZL and STELLAR on
day 0 of differentiation is not to differentiate to VASA-positive
cells by days 14 or 21.
Meiosis is a major hallmark of germ cell development; thus,
we examined expression of meiotic proteins, namely, the
synaptonemal complex protein-3, SCP3 (Fig. 8) and Mut-L
Homolog-1, MLH1 (data not shown) in differentiated EBs. In
vivo, SCP3 expression is ﬁrst detected as punctate nuclear
staining at meiotic leptotene (Fig. 8A). Subsequently, SCP3
localizes along the entire length of the sister chromatids during
the pachytene stage of meiosis with MLH1 nodules clearly
marking sites of chromosome recombination (Fig. 8B). In
undifferentiated human ES cells, only very rarely did we
observe SCP3 staining in single isolated cells (Fig. 8D) and
MLH1 staining was never observed (data not shown). By day
14 of EB differentiation, we detected cells positive for SCP3
expression frequently and throughout the EB where the protein
was localized predominantly in the cytoplasm (Fig. 8E and F),
but also in punctate SCP3-positive nuclear structures (Fig. 8G
and H). However, we did not detect MLH1 protein expression
even after 22 days of differentiation of EBs.
DISCUSSION
The use of gene expression to assess differentiation of
human ES cells
Human ES cell lines are the in vitro manifestation of cells of
the ICM derived from blastocysts. Previous reports have
demonstrated that human ES cells are pluripotent and capable
of differentiating into a wide variety of somatic cell types
during EB formation (64). However, germ cell differentiation
from human ES cells has never been reported. In this study, we
used a panel of germ cell-speciﬁc and germ cell-enriched
markers, together with markers of somatic cell lineages, to
assess the ability of three lines of undifferentiated human ES
cells to form germ cells in vitro. Several lines of evidence
suggest that this is a valid approach to assay germ cell deve-
lopment. In particular, this approach has been used successfully
to diagnose both female and male germ cell development from
ES cells in the mouse (15,16). Indeed, in the case of male germ
cells, sorting for differentiated ES cells that expressed VASA
and transplantation of these VASA-positive cells into the testis
of recipient mice results in the formation of mature sperm
in vivo. In contrast, transplantation of unsorted ES cells into the
testis of recipient mice resulted in teratoma formation from the
ES cells (16). This work provided evidence that VASA-positive
ES cells are germ cell precursors in vitro.
There is a widespread belief that ES cells express many, if not
all genes promiscuously. If this were the case, then cell-speciﬁc
marker analysis would be an inappropriate means to monitor
cell differentiation. However, several reports have documented
that ES cells express approximately the same percentage
of genes as other cell types or perhaps, just slightly more.
Approximately 20–30% of genes are expressed in stem cells in
contrast to 10–20% in most somatic cells (65–69). These
reports would indicate that ES cells do not express all genes in
a promiscuous manner. Further, in the current study we also
noted that the pattern of gene expression in the germ cell
lineage pathway is not random; it begins with expression of
known early germ cell-speciﬁc genes and proceeds to that of
later stage germ cell-speciﬁc markers. Finally, in the current
study, we connected transcription of germ cell-speciﬁc genes
to translation. No cell types, other than germ cells, are known
to express proteins such as DAZL, VASA, SCP3, GDF9 or
TEKT1 in evolutionarily divergent organisms. These observa-
tions further support the concept that sequential germ cell gene
expression upon differentiation of human ES cells recapitulates
legitimate germ cell programs, just as in the case of somatic
cell differentiation. Thus, we conclude that undifferentiated
human ES cells expressed markers of pre-meiotic germ cells
that were not expressed in isolated ICMs. Furthermore, we
observed that with ES cell differentiation into EBs, expression
of the early gonocyte speciﬁc marker VASA was initiated
together with expression of SCP3; neither of these genes were
Figure 4. Comparison of expression of a subset of genes in (A) human inner
cell mass (ICM), (B) undifferentiated ES cells, and (C) adult testis. Quantitative
PCR was used to analyzegerm cell speciﬁc expression; CT valueswere expressed
asapercentageofGAPDH(GAPDH¼100%)andusedtocalculatemeannormal-
ized expression relative to GAPDH (Table 2). Results are shown as mean and
standard deviation of three experiments.
732 Human Molecular Genetics, 2004, Vol. 13, No. 7expressed in undifferentiated ES cells or the ICM. Taken
together, our results suggested that gonocyte-like germ cells
that expressed VASA and other germ cell speciﬁc genes are
speciﬁed during human ES cell differentiation in vitro.
ES cells express markers of pre-meiotic germ cells
The genetic similarity of human ES cells to the ICM has never
been addressed. It is difﬁcult to determine a priori whether it
would be likely or not for human ES cells and ICMs to differ
signiﬁcantly in gene expression. Comparisons between cell
surface markers present on human ES cells and human ICM
cells indicate that these cell types share common antigenic
surface proﬁles and are positive for markers such as SSEA3
and SSEA4 (70). However, differences have also been noted in
that  20% of cells from undifferentiated human ES cell lines,
H7 and H14, are positive for SSEA1, a cell surface marker
that is not expressed by cells of the ICM (70). Given this
heterogeneity in cell surface markers, it may not be surprising
that genes like DAZL and NCAM1 are expressed in ES cells
even though they are not expressed in the ICM. However, the
difference between expression of other markers such as SSEA1
and expression of DAZL in undifferentiated ES cells is that,
while the former are expressed in a minority of colonies and
Figure 5. Gene expression during differentiation of human embryonic stem cells to embryoid bodies. Shown is quantitative PCR using SYBR green. The mean
normalized expression of each gene is shown along the y-axis as a function of days of differentiation as shown on the x-axis. Mean normalized expression is relative
to GAPDH.
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cell colonies of three independently derived ES lines and
in nearly every cell within a colony. Thus, since DAZL is
expressed in almost all undifferentiated ES cells, we hypothe-
size that the initial program for germ cell speciﬁcation has been
initiated in most undifferentiated human ES cells. To lend
credence to these results, we also demonstrated that undiffer-
entiated ES cells expressed other pre-meiotic genes such as
PUM2, NANOS1 and cKIT but consistently did not express
germ cell markers indicative of later stages of germ cell
differentiation such as the meiotic and post-meiotic germ cell-
speciﬁc genes VASA, SCP1, SCP3, BOULE, GDF9 and
TEKT1. As noted in studies in mice, mRNAs of other PGC-
speciﬁc genes were also expressed in mouse ES cells prior to
their differentiation; however protein expression was not
assayed (16,17). In fact, it has been suggested that perhaps
mouse ES cells resemble the ﬁve-day epiblast more closely
than cells of the ICM (71). Our results suggest that human ES
cells are likely to be distinct from ICM cells and may be more
closely related to epiblast cells or embryonic germ cells (which
are the in vitro manifestation of PGCs).
VASA as a marker of gonocyte formation with ES cell
differentiation in vitro
In the current study, one germ cell speciﬁc gene that was not
expressed in all three lines of undifferentiated ES cells or in
the ICM was VASA. Thus, fortuitously, assaying for VASA
expression during ES cell differentiation allows for identiﬁca-
tion of more mature stages of germ cells in humans, just as in
mice (15–17). When we compared expression of VASA with
that of DAZL and STELLAR, however, we noted that VASA
expression increased by day 3 of EB formation. However,
VASA-positive cells constituted only a minority of cells within
differentiating EBs. This would suggest that DAZL and
STELLAR-positive cells, which constitute the majority of
undifferentiated human ES cells in a given colony could not
contribute exclusively to VASA-positive germ cells. With
differentiation, DAZL and STELLAR positive cells were still
identiﬁed within EBs, and although we were restricted to
analyzing adjacent sections, it appears that the proteins co-
localized to the same sub-region of the EB. The precise
relationship between initial and later populations of DAZL- and
Figure 6. Immunohistochemistry of day 14 embryoid bodies. Representative immunohistochemistry of day 14 embryoid bodies from HSF-6 and HSF-1 ES cell
lines stained for VASA (A, B), STELLAR (E–G) and DAZL (H–J). Negative controls included omission of primary antibody (C) and pre-immune sera (D). Insets
magnify regions of the embryoid body, as well as individual cells, that are stained brown by immunolocalization of each protein product (black arrow heads indicate
cells stained positive for each protein whereas white arrow heads indicate negative cells). Scale bars¼100mm.
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entiating EBs is unclear. However, a potential model is as
shown in Figure 9. In addition, it should be noted that the
number of VASA positive cells is not consistent between
different EBs. The reason for this cannot be addressed at this
time. However, we hypothesize that extracellular cues or cell–
cell interactions during the earliest stages of ES cell lineage
restriction may be important in determining the number of
VASA positive cells, upon differentiation. In particular, an
extracellular source of BMP4 appears to promote additional
VASA positive cells from mouse ES cells in vitro (16).
Comparison with germ cell differentiation from
mouse ES cells in vitro
Previously, two independent studies demonstrated that mouse
ES cells could form germ cells in vitro (15,16). Both groups
took advantage of the ease of genetic manipulation of mouse
ES cells and generated undifferentiated ES cell lines that could
be sorted for a ﬂuorescent GFP marker under the control of
germ cell speciﬁc promoters. In one study, putative germ cells
were selected for GFP positive cells under the control of
the germ cell-speciﬁc Oct4 promoter (15). In these studies,
expression of mouse Vasa in the putative germ-cell population
was noted after 7 days of ES cell differentiation. In a second
study, putative germ cells were marked by a GFP reporter under
the control of the germ cell-speciﬁc mvh (mouse vasa homolog)
promoter (16). In this study, expression from the vasa locus
was ﬁrst identiﬁed after 3 days of EB differentiation (16).
Although both of these studies relied upon reporter constructs
to potentially capture germ cells as they differentiated, it was
noted that germ cell differentiation occurred spontaneously and
at an easily observed frequency. In fact, the reporter constructs
were not required to diagnose germ cell development. Here, we
report results that correlate closely with those of Toyooka and
colleagues in that expression of human VASAwas initiated after
3 days of EB differentiation and VASA-positive cells were most
often present in clusters rather than dispersed throughout the
EB (16). Moreover, in this study, we found that transcription of
later stages of germ cell differentiation including that of
the meiotic genes SCP1, SCP3, GDF9 and TEKT1 was only
initiated upon differentiation of ES cells to EBs. However, we
also observed that the ﬁdelity of meiosis, as judged by SCP3
and MLH1 staining, was severely compromised and we did not
observe formation of haploid germ cells in vitro. Like the
current study, previous studies also identiﬁed Gdf9 and Scp3
Figure 7. Percentage of cells positive for STELLAR, DAZL and VASA in day
14 embryoid bodies. The total number of positive cells was counted in the same
embryoid body on adjacent sections for STELLAR, DAZL and VASA. Results
are expressed as a percentage of cells positive for the test gene out of the total
positive cells counted for each embryoid body.
Figure 8. Meiotic protein expression. Control immunohistochemistry of SCP3
(green), and MLH1 (red) in (A) human leptotene spermatocyte, and (B) human
pachytene spermatocytes. (C and D) undifferentiated human ES cells stained
with DAPI (C) and SCP3 antisera (D). Cells from EBs at days 14 and 21 were
stained for DAPI (E–G) to detect nuclear DNA and SCP3 (F and H) to detect
chromosomes in meiosis. MLH expression in ES cells was not be detected by
immunoﬂuorescence. Scale bars¼25mm.
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formation of sister chromatids and the axial alignment of Scp3
along the length of chromosomes was not demonstrated in
these studies nor was any evidence of a haploid genome (15).
In contrast, in studies of male germ cell development, putative
germ cells were transplanted to the testis and thus may have
transited meiosis more faithfully than in vitro studies (16). In
addition, more recently, a second group has differentiated male
gametes in vitro from embryonic stem cells and found that
haploid cells form, albeit at low frequency (17). Taken together,
results from in vitro studies in mice and our current studies of
human ES cells indicated that germ cell differentiation from ES
cells to the stage of VASA expression can be achieved by
spontaneous differentiation in vitro. However, it seems likely
that completion of meiosis in vitro is inefﬁcient at best.
Conclusions
In summary, we have documented the transcriptional and
translational events of early human germ cell development in
vitro during ES cell differentiation. We propose that undiffer-
entiated ES cells are a heterogeneous population of cells that
have already initiated a pre-meiotic germ cell program as
indicated by expression of the germ cell-speciﬁc gene, DAZL.
Following differentiation to EBs, we observed the formation of
putative germ cells that expressed the germ cell speciﬁc
markers, VASA, SCP1, SCP3, BOULE, TEKT1 and GDF3.
However, we did not observe intact synaptonemal complexes
with recombination nodules and suggest that completion of
human meiosis in vitro might be promoted, more efﬁciently and
correctly, by additional germ cell factors and/or somatic cell
interactions that are native to the in vivo niche.
MATERIALS AND METHODS
Human ES cell culture
Information regarding the human ES cell lines, HSF-6, HSF-1
and H9 (NIH codes UCO6, UC01 and W-9, respectively) can be
obtained at http://stemcells.nih.gov/stemcell/. Undifferentiated
human ES cell colonies were cultured on irradiated CF1 mouse
embryonic ﬁbroblast feeder cells at 5% CO2 in supplemented
DMEM medium as previously described (38).
RNA and cDNA production
At days 0, 3, 7, 14 and 22, EBs were collected, centrifuged
and resuspended in 600ml RLT buffer (Qiagen) for RNA
extraction. Total RNA was extracted via the RNeasy system
(Qiagen) from three independently isolated samples from each
of the three different human ES cell lines used in the current
analysis. cDNA was generated from 3mg of total RNA using
250ng of random hexamers under standard conditions with
MLV reverse transcriptase (Promega). PCR was performed
with 50ng of the ﬁrst strand cDNA reaction. Three inner cell
masses (ICMs) were isolated from blastocysts by immunosur-
gery using antibody against human choriocarcinoma cells and
guinea pig complement according to standard procedures. Total
RNA from the three independently isolated ICMs was extracted
using the PicoPure RNA isolation system (Arcturus) followed
by reverse transcription and cDNA production, as above.
ICM cell cDNA was concentrated using DNA Clean and
Concentrator (ZymoResearch) and resuspended in 15ml water.
cDNA from each ICM was split into eight equal aliquots
and used to assay expression of NCAM1, OCT4, NANOS,
STELLAR, DAZL, VASA, SCP1 and GAPDH.
Quantitative PCR
Quantitative PCR reactions on human ES cell cDNA were
performed in duplicate on each sample in the presence of
4.5mM MgCl2,1 0 m M dATP, dGTP, dCTP and dTTP, 2mM
primers (Table 3), 0.25U Platinum Taq (Invitrogen), 1 SYBR
green (Molecular Probes), 1 ﬂuorosceine (Biorad) and 2%
DMSO. SYBR green PCR ampliﬁcations were initiated at 95 C
for 5min followed by 35 cycles of 95 C, 30s; 60 C, 30s; and
72 C, 30s. Quantitative PCR on human ICM cell cDNA was
performed using the Assay-on-Demand technology (Applied
Biosystems) for NCAM1, OCT4, VASA, DAZL, SCP1 and
GAPDH and Assay-by-Design (Applied Biosystems) for
NANOS and STELLAR according to manufacturer’s speciﬁca-
tions using FAM-490. Results were analyzed using an iCycler
iQ
tm (Biorad). For SYBR green, equal reaction efﬁciencies
were veriﬁed via serial dilution of testis cDNA over a 100-fold
range. Mean normalized expression was calculated using
REST
TM XL software (Relative Expression Software Tool)
(72). All experiments included negative controls with no cDNA
for each primer pair. Primers were designed to span exons to
distinguish cDNA from genomic DNA products.
Western blot analysis
Western blot analysis was performed according to standard
procedures (3). Antibody dilutions were rabbit-anti human
PUM2 (1/500), rabbit anti-human OCT4 (1/500), rabbit anti-
human NANOS (1/500), rabbit anti-human DAZL (149 and
150; 1/500), chicken anti-human VASA (1/500), rabbit anti-
human BOULE (1/500) and rabbit anti-human SCP3 (1/5000).
OCT4 was purchased (Active Motif).
Hypotonic immunohistochemistry for meiotic markers
Human ES cells at day 0 were digested for 15min at 37 C with
1mg/ml collagenase type IV/1mg/ml dispase (Gibco BRL) in
Figure 9. Model of speciﬁcation of human germ cells based on gene expression
in the inner cell mass and ES cell differentiation. See text for further explanation.
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knockout serum replacer (Gibco BRL), 1mM glutamine (Gibco
BRL), non-essential amino acids (Gibco BRL), 0.1mM b-
mercaptoethanol (Sigma Chemical) and 4ng/ml FGF2 (R&D
Systems). Colonies were gently dislodged, centrifuged at
1000rpm, 5min, and then resuspended in freshly prepared
hypoextraction buffer pH 8.2 (30mM Tris pH 8.2/50mM
sucrose/17mM citric acid/5mM EDTA/0.5mM DTT/0.5mM
Pefabloc; Gibco BRL). EBs and ES cell colonies were then
lightly teased apart before further incubation in hypoextraction
buffer for 30min. ES cell colonies and EBs were then collected
into 100mM Sucrose before teasing apart using 20gage needles
to form a single cell suspension. The single cell suspensions
were pippetted onto glass slides, previously treated with 1%
paraformaldehyde in PBS pH 9.2 containing 0.25% Tween 20.
The slides were then in 0.04% photoﬂo (KODAK) in distilled
H2O followed by incubation for 30min in Antibody Dilution
Buffer (ADB) containing 10% Normal Donkey Serum (Jackson
ImmunoResearch Laboratories)/3% BSA (Sigma Chemical)/
0.5% Tween 20 (Sigma Chemical). Slides were incubated
overnight at 37 C with rabbit anti-human SCP3 (a gift from
Christa Heyting, Wageningen University) and mouse anti-rat
MLH (Ongogene) diluted in ADB at 1/500 and 1/25,
respectively. Slides were washed for 10min in ADB followed
by 24h in ADB at 4 C. Slides were incubated with secondary
antibodies (rhodamine-conjugated anti-mouse for MLH; FITC-
conjugated anti-rabbit for SCP3; 1/100 dilution), 45min at
37 C. Slides were washed four times in PBS and sealed under a
coverslip with anti-fade mounting media (Molecular Probes).
Immunohistochemistry on parafﬁn-embedded
tissue sections
Human testis specimens were ﬁxed by immersion in Bouin’s
ﬁxative (VWR Scientiﬁc); EBs were ﬁxed in 4% paraformal-
dehyde in PBS (pH 7.4), 1h, processed to parafﬁn, and cut at
5mm serial sections onto slides. Slides were blocked by
incubation in PBS/0.1% BSA/0.3% Tween 20 (PBST)/10%
normal goat serum as appropriate (Vector Laboratories) for
30min. Slides were incubated with primary antibody over-
night at 4 C (rabbit anti-human DAZL; 1/100; rabbit anti-
human STELLAR: 1/1000 [antibodies made against peptide
sequence RESVGAAVLREIEDE of human STELLAR (58);
chicken anti-human VASA, 1/1000] in PBST before washing
twice for 10min in PBS. Sections were then incubated twice
for 10min in PBS before mounting under a glass coverslip
with anti-fade mounting media (Molecular Probes). For avidin
biotin immunohistochemistry, following incubation in primary
antibodies, sections were incubated for 30min at room tem-
perature, with either biotin conjugated anti-rabbit (Vector
Laboratories) to detect DAZL and STELLAR according to
manufacturer’s instructions, or biotin conjugated anti-chicken
(1/200; Sigma Chemical) to detect VASA. Sections were
washed twice for 10min in PBS followed by incubation for
30min in ABC reagent (Vector Laboratories). Sections were
then washed twice for 10min in PBS, and incubated in DAB
(Vector Laboratories) until the brown color reaction deve-
loped. Color reactions were stopped in deionized H2Ob e f o r e
dehydrating sections through ascending concentrations of
ethanol to xylene. Sections were permanently mounted under
glass coverslips using Vectormount (Vector Laboratories).
Whole mount immunohistochemistry
Undifferentiated human ES cells were grown on feeder layers
for at least 4 days before removing the media and ﬁxing in 4%
paraformaldehyde in PBS (pH 7.4) for 15min. Colonies were
then washed twice for 10min in TBS þ 0.05% Tween 20
(TBST), followed by incubation in 0.1% Triton X in PBS for
10min. Colonies were washed as above, incubated for 30min
with 4% normal donkey serum (Jackson ImmunoResearch
Laboratories), and incubated with primary antibodies diluted in
PBS [1/100, DAZL; 1/100, STELLAR; 1/1000, VASA; 1/30
SSEA1; 1/30 SSEA3; 1/30 SSEA4; 1/30 TRA-1-81; 1/30
TRA-1-60 (all from Chemicon International Temecula, CA,
USA); 1/50 NCAM1; 1/50 KDR (Assay Designs Inc., Ann
Arbor, MI, USA) and neat AFP (Becton Coulter) for
immunoﬂuorescence]. For Avidin–biotin immunohistochemis-
try antibodies were diluted (1/500, DAZL; 1/1000, STELLAR;
1/1000 VASA in PBS). All primary antibodies were incubated
for 1h at room temperature. Colonies were then washed twice
in PBS and incubated with secondary antibodies as described
above. Colonies were viewed using a Leica microscope ﬁtted
for immunoﬂuorescence after mounting with anti-fade mount-
ing media or PBS (DAB).
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